🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety and efficacy of subcuta...
Status
Completed
Location
Multiple Locations
Start Date
2005-12
Trial ID
NCT00265083
Treatments Being Tested
This is a Phase 1, pharmacokinetic and pharmacodynamic study of intravenous...
Status
Completed
Location
Multiple Locations
Start Date
2007-12-26
Trial ID
NCT01362153
The purpose of this study is to evaluate the efficacy and safety of golimum...
Status
Completed
Location
Multiple Locations
Start Date
2005-12
Trial ID
NCT00264537
The purpose of this study is to evaluate the safety and effectiveness of go...
Status
Completed
Location
Multiple Locations
Start Date
2008-05
Trial ID
NCT00727987
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of golimum...
Status
Completed
Location
Multiple Locations
Start Date
2006-02
Trial ID
NCT00299546
Treatments Being Tested
The primary objective of this study is to evaluate the efficacy of golimuma...
Status
Completed
Location
Merck Sharp & Dohme Ltd.
Start Date
2014-05-09
Trial ID
NCT02092285
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of golimum...
Status
Completed
Location
Multiple Locations
Start Date
2005-12
Trial ID
NCT00264550
Treatments Being Tested
The purpose of this study is to assess the efficacy of ustekinumab, in adul...
Status
Terminated
Location
Multiple Locations
Start Date
2015-09-03
Trial ID
NCT02437162
Treatments Being Tested
The purpose of this study is to evaluate the accuracy of a subset of the le...
Status
Completed
Location
Multiple Locations
Start Date
2013-12
Trial ID
NCT01988961
Treatments Being Tested
The purpose of this study is to assess the safety and efficacy of golimumab...
Status
Completed
Location
Multiple Locations
Start Date
2007-09
Trial ID
NCT00488631
Treatments Being Tested